WARSAW, Ind., Nov. 10, 2011 — /PRNewswire/ — Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has acquired Memphis-based ExtraOrtho, Inc., including its external fixation line, XtraFix External Fixation System.
“This acquisition further enhances Zimmer’s position in the vital and growing external bone fixation market,” said Jeff Paulsen, President, Zimmer Global Businesses. “The XtraFix technology is one of the most simple and effective solutions for external fixation, and we’re confident that trauma care professionals will welcome this addition to Zimmer’s comprehensive portfolio of external and internal fixation products.”
In response to a series of recently introduced new technologies, Zimmer has become one of the industry’s fastest growing companies in the $5.5 billion global trauma market. The acquisition of ExtraOrtho broadens Zimmer’s portfolio of Trauma solutions and strengthens the Company’s position in the $820 million external fixation market. The XtraFix External Fixation System can be used for unilateral and multilateral fixation of long bones, wrist, ankle and pelvic fractures.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer’s 2010 sales were approximately $4.2 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.
Founded in 2007 under the name QFx Technologies, Inc., ExtraOrtho Inc. is a medical device company focused on bringing innovation to the Trauma external fixation market. ExtraOrtho launched the patented XTRAFIX® damage control fixation system in January 2011.
We routinely post important information for investors on our website, www.zimmer.com, in the “Investor Relations” section. We intend to use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor Relations section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management’s beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,” “estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” and “seeks” or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.
SOURCE Zimmer Holdings, Inc.